JSW Dulux Q2 FY27 Results Analysis: Volumes Surge 21%, Margin Misses Guidance (JSWDULUX)
JSW Dulux Ltd's Q2 FY27 numbers came in soft. Here's a quick read of what worked, what to watch, and what management said.
| Results date | November 04, 2026 |
|---|---|
| Revenue (Q2) | Rs. 961.90 Cr (+16.23% YoY) |
| PAT (Q2) | Rs. 71.20 Cr |
| EBITDA margin | 11.53% (-183 bps YoY) |
| EPS (Q2) | Rs. 15.63 |
Quarter Snapshot
Q2 FY27 delivered 21% volume growth and 21.3% comparable revenue growth, but EBITDA margin of 11.53% missed all of management's guided bands (13-15% latest) and slipped further QoQ as raw-material costs grew 38% against 16% revenue growth. Underlying PAT grew only 2.01% on the clean basis, with growth consuming working capital (inventories +42% since March). The volume franchise and debt-free balance sheet remain intact, but the margin-repair promise due by August-September 2026 was not delivered.
Q2 FY27 Expectations vs Results
| Driver | Expected before results | What happened | Verdict |
|---|---|---|---|
| Revenue | "revenue likely in line to ahead, skewed by price/mix" | +16.23% reported, +21.3% comparable | Played out |
| Volume | double-digit at risk late-quarter vs a rival priced 12–18% lower | +21% volume | Played out |
| EBITDA margin | "recovery from Q1's 11.93% toward the guided 13–15% band looks behind the Aug–Sep deadline" | 11.53% — below every band, down 40 bps QoQ | Played out |
| One-offs | "Q2 reverts from the Rs.55.9 Cr dividend and Rs.21.5 Cr refund-interest base; consolidated PAT converging toward standalone" | Other income Rs.2.4 Cr; consol PAT Rs.71.4 Cr vs standalone Rs.71.2 Cr | Played out |
| TiO2 duty | reimposition after the quarter is a Q3-onward cost item (per pre-call note, web-sourced, dated 24 Oct 2026) | Not addressed in this filing | Not observable |
| GST contingency / provisioning stance | live SCNs | Not addressed in this filing — remains open | Not observable |
Management Guidance vs Delivery
| What management said | Where | What happened | Verdict |
|---|---|---|---|
| EBITDA margin 13–15% | Q1 FY27 earnings call, "given the crude prices" | 11.53% | Missed |
| EBITDA margin 14.5–15% ex-synergies | Q3 FY26 earnings call | 11.53% | Missed |
| EBITDA margin 14–16% "on a sustained basis" | Q2 FY26 earnings call | 11.53% | Missed |
| Margin impacts to "neutralize by August-September 2026" | Q4 FY26 earnings call | 11.53% vs 11.93% in Q1 — slipped further, not neutralized | Missed |
| Double-digit volume and value growth | Reiterated on the Q1 FY27 call; CEO quote in the media release: "consecutive quarter of double-digit volume and value growth" | Volume +21%; comparable revenue +21.3% | Met |
| Debt-free status (maintain) | Prior earnings calls | No borrowings on the 30 Sep 2026 balance sheet | On Track |
Key Investment Insights
Key Positives
- Revenue grew 16.23% YoY reported (Rs.961.9 Cr) and 21.3% on the comparable retained-business basis
- Volume grew 21% YoY; H1 volume +23%
- Comparable EBITDA grew 4.4% YoY (Rs.110.9 Cr vs Rs.106.3 Cr) despite raw-material inflation
- Employee costs fell 2.62% YoY and other expenses grew 11.67% YoY, slower than revenue
- H1 operating cash flow of Rs.141.7 Cr vs an outflow of Rs.(202.5) Cr in H1 FY26
- Company remains debt-free with no borrowings on the 30 Sep 2026 balance sheet
- Q2 is a clean quarter with other income of only Rs.2.4 Cr (0.25% of revenue) and no exceptional items
Risk Factors
- EBITDA margin of 11.53% missed management's guided bands of 13-15%, 14.5-15% ex-synergies, and 14-16% sustained, and slipped 40 bps QoQ
- Cost of materials consumed grew 38.05% YoY vs revenue growth of 16.23%; gross margin compressed to 36.78% from 40.77% LY
- PAT-ex-exceptionals grew only 2.01% on 21% volume growth; reported EBITDA was flat (+0.27% YoY)
- Inventories rose 42.16% since March (Rs.240.8 Cr build) and H1 CFO/PAT-ex-exceptionals was 0.686x
- Comparable revenue growth approximating volume growth implies negative price/mix on the retained base against competitors priced 12-18% lower
- Finance costs doubled to Rs.4.5 Cr (+95.65% YoY)
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.